=EF=BB=BFMelanotan 1 vs Melanotan 2: Same Starting Point,= Very Different Compounds 3D""

=CD=8F =E2=80=87 =C2= =AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F = =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD= =CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2= =80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD= =8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80= =87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F= =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87= =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F &n= bsp; =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2= =AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F = =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD= =CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2= =80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD= =8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80= =87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F= =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87= =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F &n= bsp; =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2= =AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F = =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD= =CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2= =80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD= =8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80= =87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F= =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87= =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F &n= bsp; =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2= =AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F = =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD= =CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2= =80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD= =8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80= =87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F= =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87= =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F &n= bsp; =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2= =AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F = =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD= =CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2= =80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD= =8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80= =87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F= =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87= =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F &n= bsp; =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2= =AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F = =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD= =CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2= =80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD= =8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80= =87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F= =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87= =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F &n= bsp; =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2= =AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F = =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD= =CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2= =80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD= =8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80= =87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F= =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87= =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F &n= bsp; =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2= =AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F = =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD= =CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2= =80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD= =8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80= =87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F= =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87= =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F &n= bsp; =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2= =AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F = =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD= =CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2= =80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD= =8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80= =87 =C2=AD=CD=8F =E2=80=87 =C2=AD=CD=8F =E2=80=87 =C2=AD

Forwarded this email? S= ubscribe here for more

Melanotan 1 vs Melanotan 2: Same Star= ting Point, Very Different Compounds

Derek

Mar 17=

For research and educational purposes o= nly. Not medical advice.

These two get lumped together consta= ntly. Same name, same origin, similar purpose =E2=80=94 so people assume the= y=E2=80=99re basically the same thing with different numbers. They=E2=80=99r= e not. Understanding why requires a quick look at what each one is actually d= oing at the receptor level.

Where They Come From

Both MT1 and MT2 w= ere developed at the University of Arizona as synthetic analogs of alpha-mel= anocyte stimulating hormone =E2=80=94 =CE=B1-MSH =E2=80=94 a naturally occur= ring peptide your body already produces. =CE=B1-MSH plays a central role in r= egulating pigmentation, appetite, inflammation, and sexual function by bindi= ng to a family of receptors called melanocortin receptors (MC1R through MC5R= ).

The researchers weren=E2=80=99t trying to create a tanning= peptide. They were trying to understand the melanocortin system =E2=80=94 a= nd in doing so, built two analogs that interact with it very differently.

The Mechanism: Why Structure Matters

MT1 is a linear peptide, meaning its amino acid chain runs straight. MT2 is= cyclic =E2=80=94 the chain loops back on itself. That=E2=80=99s not a minor= detail. It fundamentally changes which receptors each compound binds to and= how strongly.

Your skin contains melanocytes =E2=80=94 cells= responsible for producing melanin, the pigment that gives skin its color. T= hose melanocytes express MC1R on their surface. When =CE=B1-MSH (or a synthe= tic analog) binds to MC1R, it triggers a signaling cascade that upregulates m= elanin production. More melanin means darker skin. This is the core tanning m= echanism both compounds share.

Where they diverge is receptor= selectivity.

MT1 binds primarily to MC1R. That=E2=80=99s lar= gely where its activity begins and ends. The result is targeted melanin stim= ulation with minimal downstream effects at the other receptors.

MT2 binds to MC1R as well =E2=80=94 but it also has meaningful activity at M= C3R, MC4R, and MC5R. MC4R in particular is expressed heavily in the hypothal= amus and is involved in regulating appetite, energy balance, and sexual func= tion. This is why MT2 produces appetite suppression and sexual effects that M= T1 doesn=E2=80=99t. It=E2=80=99s not a bonus =E2=80=94 it=E2=80=99s a direct= consequence of its broader receptor profile. And that same breadth is what d= rives the more pronounced side effects.

Think of it this way:= MT1 is a targeted signal to your melanocytes. MT2 is a louder, less specifi= c signal that hits multiple systems at once.

What That Lo= oks Like in Practice

MT1 produces a gradual, even ta= n. Existing freckles and moles will darken =E2=80=94 this is expected, since= those areas already have higher melanocyte activity. The effect builds over= weeks and is dose-dependent. Outside of that, the functional impact is mini= mal.

MT2 produces the same tanning effect, plus appetite supp= ression that some research subjects find significant, plus pro-erectile and l= ibido-related effects driven by MC4R activity. You=E2=80=99re essentially ge= tting multiple systems activated from a single compound.

The t= radeoff is side effects. Nausea with MT2 is common, particularly during the l= oading phase, and is tied to MC4R and MC3R activity in the gut and brain. Fa= cial flushing occurs for similar reasons. MT1=E2=80=99s side effect profile i= s considerably milder =E2=80=94 some nausea, occasional flushing, but at muc= h lower rates and severity.

Safety Data

This is where MT1 has a meaningful advantage. It=E2=80=99s been throug= h formal clinical trials and holds regulatory approval in Europe and Austral= ia under the brand name Scenesse, used to treat erythropoietic protoporphyri= a =E2=80=94 a rare disorder that causes severe light sensitivity. That appro= val doesn=E2=80=99t extend to cosmetic tanning, but it does mean MT1 has doc= umented human safety data that MT2 simply doesn=E2=80=99t have.

The open question for both compounds is long-term melanocyte stimulation an= d melanoma risk. Activating MC1R repeatedly over time =E2=80=94 and by exten= sion, continuously pushing melanocytes to produce melanin =E2=80=94 is not s= omething we have definitive long-term data on in healthy individuals using t= hese compounds cosmetically. MT1=E2=80=99s selectivity may theoretically car= ry a lower risk profile than MT2=E2=80=99s broader activity, but that remain= s an open question, not a confirmed advantage.

Both require t= he same baseline precautions: dermatology appointment before starting, photo= documentation of existing moles, and regular skin checks going forward.

Dosing

MT1=E2=80=99s shorter half-life= means more frequent dosing to sustain the effect.

MT1:

Start: 0.25=E2=80=930.5mg to assess tolerance

Loading: 0.5=E2=80=931mg daily for 2=E2=80= =934 weeks

Maintenan= ce: 0.5=E2=80=931mg 2=E2=80=933x per week

MT2:

<= ul style=3D"margin-top: 0;padding: 0;">

Start: 0.1=E2=80=930.25mg to assess tolerance

Loading: 0.25=E2=80=930.5mg daily for 1=E2= =80=933 weeks

Mainten= ance: 0.5mg 1=E2=80=932x per week

MT2 achieves a com= parable tan at lower doses and less frequent intervals. The convenience adva= ntage is real. Whether it outweighs the side effect profile depends on what y= ou=E2=80=99re optimizing for.

How to Choose

MT1 makes more sense if tanning is your only objective, if you had= a rough time tolerating MT2, or if you want the compound with more clinical= data behind it. It costs more per dose and requires more frequent administr= ation =E2=80=94 those are the real tradeoffs.

MT2 makes more s= ense if you want the broader effect profile, if dosing convenience matters, o= r if you=E2=80=99ve used it before and handle it well. It=E2=80=99s also mor= e cost-effective.

Combining them is an option some people use= to get the tanning benefit of MT1 while running low-dose MT2 for the other e= ffects =E2=80=94 reducing the MT2 dose needed and keeping side effects more m= anageable. Most people won=E2=80=99t need to go that route, but it=E2=80=99s= a legitimate approach for those who know how they respond to each.

On Sun Exposure

Both compounds stimulate me= lanin production independent of UV exposure, but UV does accelerate and deep= en the effect. The mistake is treating that as license to spend more time in= direct sun. It isn=E2=80=99t. The goal is achieving color with less UV =E2=80= =94 not using a peptide as cover for adding more.

Questions below= . Keep it research-focused.

You're curre= ntly a free subscriber to Peptide= Price. For the full experience, upgrade your= subscription.

Upgrade to paid=

<= a class=3D"email-icon-button" href=3D"https://substack.com/app-link/post?pub= lication_id=3D3365367&post_id=3D191285147&utm_source=3Dsubstack&= utm_medium=3Demail&utm_content=3Dshare&utm_campaign=3Demail-share&am= p;action=3Dshare&triggerShare=3Dtrue&isFreemail=3Dtrue&r=3D4iwoe= 6&token=3DeyJ1c2VyX2lkIjoyNzM2MjIzOTgsInBvc3RfaWQiOjE5MTI4NTE0NywiaWF0Ij= oxNzczNzcyNTQ3LCJleHAiOjE3NzYzNjQ1NDcsImlzcyI6InB1Yi0zMzY1MzY3Iiwic3ViIjoicG= 9zdC1yZWFjdGlvbiJ9.mu_4O5tIOalzDINplmMI0Ny3R8A-PN4CTdjHfxW4hS8" style=3D"fon= t-family: system-ui,-apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helve= tica,Arial,sans-serif,'Apple Color Emoji','Segoe UI Emoji','Segoe UI Symbol'= ;display: inline-block;font-weight: 500;border: 1px solid rgb(0,0,0,.1);bord= er-radius: 9999px;text-transform: uppercase;font-size: 12px;line-height: 1;p= adding: 9px 0;text-decoration: none;color: rgb(119,119,119);min-width: 38px;= box-sizing: border-box;width: 38px">

<= tr>

<= /div>READ IN APP

<= td height=3D"16" style=3D"font-size:0px;line-height:0;">

Comment

Restack

<= /tbody> 3D""